asthma news from FiercePharma
NewsAZ stock falls on Symbicort patent loss
What a difference one patent ruling can make. AstraZeneca lost almost $1.3 billion in market value today after announcing that the European Patent Office yanked a patent covering its blockbuster Read more...
FDA nixes Merck, Schering allergy combo
In another blow to the Merck/Schering-Plough joint venture, the FDA rejected a proposed allergy and asthma treatment that would have Read more...
Incontinence meds may impair thinking
Commonly used incontinence drugs may cause memory problems in older people, according to a new study funded by the National Institute on Aging. "Our message is to be careful when using these Read more...
SPOTLIGHT: FDA asks for data on asthma meds
The FDA has asked the makers of several beta agonist drugs for more data from clinical trials so it can "further evaluate the safety" of the drugs when used to treat asthma. Once the data is Read more...
NIH unveils new asthma guidelines
New asthma treatment guidelines could be good news for drug companies. The government advises better day-to-day control of the disease--and that probably means more widespread use of inhaled Read more...
| Press ReleasesNIH: National Asthma Guidelines Updated National Asthma Guidelines Updated New Approaches for Monitoring Asthma Control, Expanded Recommendations for Children The National Asthma Education and Prevention Program (NAEPP) today issued the Read more... |
Get more asthma coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight